Dr Ashleigh Osborne (MHlthSc, Hons I, PhD) is an experienced Medical Affairs professional and cannabinoid researcher who serves as Medical & Research Director for Medigrowth Australia and holds an Affiliate Lecturer position with Deakin University. Ashleigh has been in the cannabinoid field since 2013 - before medicinal cannabis was legalised in Australia - and brings over 13 years of expertise, including a PhD focused on the therapeutic potential of CBD. 

Ashleigh’s scientific contributions are well recognised with her cannabinoid research published in several high impact, peer-reviewed international journals, accumulating almost 600 citations to date. She has presented at numerous national and international scientific conferences, and her work has been supported by grants from government, universities, and non-profit organisations. 

With a strong focus on cannabinoid science, Ashleigh has over 7 years of experience across the pharmaceutical and medical device industries with global companies, during which she has educated thousands of healthcare professionals in quality use of medicines and medical vaporisers to transform patient care. 

Ashleigh is deeply passionate about improving outcomes for patients, empowering healthcare professionals, and driving medical education and research to advance cannabinoid-based medicine.